Biogenity ApS
CVR 39606925 · Private limited company (ApS) · Active · Medium risk
Biogenity ApS is a Private limited company (ApS), founded on , based in Aalborg Øst. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 7 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK -190k and a net result of DKK -454k. CEO: Louis Loeb.
Bankruptcy risk for Biogenity ApS
1.1 × the average (1.41%) · higher risk than 79% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39606925
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Niels Jernes Vej 10
9220 Aalborg Øst - Municipality
- Aalborg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 80k
- Auditor
- Redmark, Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 7 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -10.8% |
| Current ratio | 89% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 265 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 1.4m | DKK 1.9m |
| Net profit | DKK -454k | DKK -343k |
| Equity | DKK -190k | DKK 264k |
| Total assets | DKK 1.8m | DKK 1.1m |
| Cash | DKK 686k | – |
| Short-term debt | DKK 2.0m | – |
| Tax owed | DKK 0 | – |
| Avg. employees | 4 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Redmark, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 175 | ||
| 1 Jul 2023 – 30 Jun 2024 | 175 | ||
| 1 Jul 2022 – 30 Jun 2023 | 173 | ||
| 1 Jul 2021 – 30 Jun 2022 | 95 | ||
| 1 Jul 2020 – 30 Jun 2021 | 121 | ||
| 1 Jul 2019 – 30 Jun 2020 | 73 | ||
| 30 May 2018 – 30 Jun 2019 | 86 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Louis Loeb | Current | |
| CEO | Søren Buch Jensen | ||
| CEO | Søren Buch Jensen | ||
| Board | Kenneth Kastaniegaard | Current | |
| Board | Louis Loeb | Current | |
| Board | Louis Loeb | ||
| Board | Søren Buch Jensen | ||
| Board | Søren Buch Jensen | ||
| Owner (50%) | L.Loeb Holding ApS | Current | |
| Owner (50%) | Kastaniegaard Holding ApS | Current | |
| Owner (33%) | S.Buch Holding IVS | ||
| Owner (33%) | SBJensen Holding IVS | ||
| Founder | L.Loeb Holding ApS | Current | |
| Founder | Kastaniegaard Holding ApS | Current | |
| Founder | S.Buch Holding IVS | Current |
The CEOs' other companies
Louis Loeb – 4 other companies
- Komma.Design ApS Compulsorily dissolved
- L.Loeb Holding ApS Active
- Loeb Holding IVS Opløst
- Omics Studio ApS Active
Søren Buch Jensen – 2 other companies
- S.Buch Holding IVS Compulsorily dissolved
- SBJensen Holding IVS Compulsorily dissolved
Address history (3 moves)
| Niels Jernes Vej 10, 9220 Aalborg Øst | |
| c/o 2A Pharma, Niels Jernes Vej 10, 9220 Aalborg Øst | |
| Dalgasgade 19, 3., 9000 Aalborg | |
| c/o Kenneth Kastaniegaard, Himmerlandsgade 16, st. tv, 9000 Aalborg |
Former names
| Biogenity ApS | – now |
| Biogenity IVS | – |
Other companies at the same address
- 2N Pharma ApS Bankrupt
- 2N Pharma Holding ApS Bankrupt
- AINES 2022 ApS Bankrupt
- AKTIESELSKABET AF 09.01.02 Bankrupt
- AMPHIDEX A/S Bankrupt
- AX INNOVATION ApS Bankrupt
- CAD CAM CONSULT ApS. AALBORG Bankrupt
- CAD CAM DEVELOPMENT ApS Bankrupt
- DOCOSPOT DENMARK ApS Bankrupt
- ECO-LocaXion Management ApS Bankrupt
- EKKO DANE A/S Bankrupt
- INTERACT ApS Bankrupt
- JTP GROUP ApS Bankrupt
- MALLING SENSORS A/S Bankrupt
- NETNORD A/S Bankrupt
- PANACOUSTIC A/S Bankrupt
- PCOM: I3 ApS Bankrupt
- PINOCCHIO DATA SYSTEMS ApS Bankrupt
- PIPETECH INNOVATION ApS Bankrupt
- RED RIVER ApS Bankrupt
- SARR ApS Bankrupt
- SHIMA COMMUNICATION A/S Bankrupt
- Selskabet af 20-09-2024 ApS Bankrupt
- Senia Core ApS Bankrupt
- Senia Home ApS Bankrupt
Similar companies in Aalborg
- Neurometa Therapeutics ApS Aalborg Øst
- 2A Pharma ApS Aalborg Øst
- Methyl Detect ApS Aalborg Øst
- EEGTRAINING NORD ApS Vestbjerg
- DNASENSE ApS Aalborg Øst
- C4PAIN ApS Aalborg
- OLE USSING ApS Aalborg
- REDO-Neurosystems ApS Aalborg
- 2N Pharma ApS Aalborg Øst
- ClearDynamic ApS Nørresundby
- The Froglet IVS Aalborg
- EMProS IVS Gistrup
Questions and answers about Biogenity ApS
Has Biogenity ApS gone bankrupt?
No, Biogenity ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Biogenity ApS?
Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.
Who is the CEO of Biogenity ApS?
Louis Loeb is the CEO of Biogenity ApS.
Who is the auditor of Biogenity ApS?
Biogenity ApS most recently used Redmark, Godkendt Revisionspartnerselskab.
When was Biogenity ApS founded?
Biogenity ApS was founded on 30 May 2018.
What is the equity of Biogenity ApS?
Equity was DKK -190k according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.